Can You Regain Weight After Stopping Mounjaro?

It’s a fair question, and one many people ask before starting treatment: what happens when you stop Mounjaro? If you’ve worked hard to lose weight, you understandably want to keep it off. The short answer is that weight regain is common after stopping tirzepatide (the active ingredient in Mounjaro), but there are ways to reduce the risk and keep more of your progress intact.

Introduction

Mounjaro (tirzepatide) is a once-weekly injection that targets appetite and blood sugar signals, helping many people lose a substantial amount of weight alongside healthy lifestyle changes. The tricky bit comes later: stopping the medicine often lifts that helpful “brake” on hunger and fullness, which can make weight maintenance harder. Understanding why this happens—and what you can do about it—can help you plan ahead with confidence.

What We Know From Studies

Clinical trials give a clear picture of what tends to happen after stopping tirzepatide. In a large study called SURMOUNT-4, people first used tirzepatide for 36 weeks and lost about one-fifth of their body weight on average; they were then randomised to either continue tirzepatide or switch to placebo for another year. Those who continued lost a little more, while those who stopped regained around 14% of their body weight over that year. Most who kept taking tirzepatide maintained the majority of their weight loss, but only a minority did so after stopping.

These findings match broader evidence on medicines in this class: a number of reviews show significant weight regain after stopping GLP-1–based therapies, with larger initial losses often followed by greater regain when treatment ends. Put simply, obesity behaves like a long-term condition—so support often needs to be long-term too.

Why Regain Happens After Stopping

Tirzepatide works by mimicking two hormones—GLP-1 and GIP—that help you feel fuller, slow stomach emptying, and steady blood sugar after meals. When you stop, those helpful signals reduce, and appetite can creep back up, making it easier to eat more without quite noticing. Metabolism may also nudge upward from its treatment-lowered state, making maintenance a little tougher without active support.

None of this means weight regain is inevitable, but it does explain why it’s common and why a plan for maintenance is so important.

Planning for Maintenance: Practical Steps

A good maintenance plan starts before the final dose. The aim is to “swap in” routines that help you keep the benefits even as the medicine’s effects fade.

Lock in regular meals with protein and fibre to support fullness and steady energy.
Keep moving—mix brisk walking or cycling with two short strength sessions weekly to preserve muscle and support metabolism.
Track the trends—weekly weigh-ins or waist measurements help you catch small changes early and make timely adjustments.
Prepare for appetite changes—expect hunger to increase a bit; pre-plan satisfying, balanced snacks and keep simple, healthy meals on rotation.
Build support—check-ins with a clinician, a dietitian, or a group can improve accountability and confidence during the transition.

Some people and clinicians consider longer-term treatment if it’s working and well-tolerated, reflecting the chronic nature of obesity care; recent UK guidance acknowledges that tirzepatide may be continued longer term alongside lifestyle support when clinically appropriate.

Expert Insights

“Obesity is a chronic condition, like diabetes or high blood pressure. So, it must be treated chronically.” Trial results suggest that people who stop tirzepatide regain a meaningful portion of lost weight, whereas those who continue tend to maintain or add to their progress. NICE also positions tirzepatide as part of ongoing, wrap-around care with diet and activity support, underscoring the importance of long-term management.

Real-World Experiences

People often describe a noticeable shift in appetite once they stop. In line with trial findings, many report that discontinuation can lead to weight creeping back, while continued treatment helps to maintain losses. A common theme is that staying consistent with meals and exercise becomes the difference between holding steady and gradually regaining.

When Stopping Might Make Sense

You and your clinician may decide to pause or stop for side effects, life events, pregnancy planning, or because you’ve reached a personal goal and want to try maintaining without medication. If so, it helps to agree a plan for close follow-up and to revisit options if significant regain appears despite best efforts.

Risks & Considerations

Regain is common after stopping and can reverse some improvements in blood pressure, glucose and lipids seen during treatment, although many people still remain lighter than when they started.

If severe hunger or rapid regain occurs, seek advice early; adjusting lifestyle strategies or reconsidering medical options can help.

Key Takeaways

Weight regain after stopping Mounjaro is common; studies show an average regain of about 14% of body weight within a year of discontinuation.
Continuing tirzepatide helps most people maintain the majority of their weight loss, reflecting obesity’s chronic nature.
Planning ahead—protein- and fibre-rich meals, regular activity (including strength work), and weekly monitoring—reduces the risk of regain.
Expect appetite to increase after stopping; structured routines and support make a real difference.
UK guidance supports tirzepatide as part of long-term, wrap-around lifestyle care when clinically appropriate.

Staying prepared, supported, and flexible gives the best chance of keeping hard-won progress going strong.

For pricing and availability, check our price comparison tool.